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Background: Stricture formation is a common complication of Crohn’s disease (CD), occurring 
in approximately one-third of all patients with this condition. Our aim was to summarize the 
available epidemiology data on strictures in patients with CD, to outline the principal evidence 
on diagnostic imaging, and to provide an overview of the current knowledge on treatment 
strategies, including surgical and endoscopic options. Overall, the unifying theme of this nar-
rative review is the multidisciplinary approach in the clinical management of patients with 
stricturing CD.
Methods: A Medline search was performed, using “Inflammatory Bowel Disease”, “stricture”, 
“Crohn’s Disease”, “Ulcerative Colitis”, “endoscopic balloon dilatation” and “strictureplasty” 
as keywords. A selection of clinical cohort studies and systematic reviews were reviewed.
Results: Strictures in CD are described as either inflammatory or fibrotic. They can occur de 
novo, at sites of bowel anastomosis or in the ileal pouch. CD-related strictures generally show 
a poor response to medical therapies, and surgical bowel resection or surgical strictureplasty 
are often required. Over the last three decades, the potential role of endoscopic balloon dilata-
tion has grown in importance, and nowadays this technique is a valid option, complementary 
to surgery.
Conclusion: Patients with stricturing CD require complex clinical management, which benefits 
from a multidisciplinary approach: gastroenterologists, pediatricians, radiologists, surgeons, 
specialist nurses, and dieticians are among the health care providers involved in supporting 
these patients throughout diagnosis, prevention of complications, and treatment.
Keywords: Crohn’s disease, endoscopic balloon dilatation, multidisciplinary team, stricture, 
strictureplasty
Introduction
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gut, 
which includes conditions such as Crohn’s disease (CD), ulcerative colitis (UC), and 
IBD-unclassified. Endoscopy and histological examination of the gastrointestinal 
biopsies represents the gold standard for the diagnosis of IBD. It allows us to assess 
the extent of IBD, to estimate the success of treatments, to monitor the disease course, 
and to treat some of its complications.1,2 The Vienna Classification first described three 
distinct groups of CD behavior: inflammatory, stricturing, and penetrating. An associa-
tion between disease location and behavior is demonstrated, and stricturing disease 
mostly involves the terminal ileum and the ileocolonic locations.3
Stricture formation is a common complication of CD, occurring in approximately 
one-third of all patients with this condition.4 Such complication is the result of chronic 
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inflammation within the intestinal walls and the continuous 
healing response, which can lead to a progressive narrowing 
of the lumen and an increased pressure gradient around the 
stricture.5 CD-related strictures are defined as a persistent 
luminal narrowing, which can remain clinically silent or 
manifest with prestenotic dilatation and obstructive symp-
toms, such as abdominal bloating, distention, and pain.5,6 
Strictures in CD are described as either inflammatory or 
fibrotic. They can occur de novo, at sites of bowel anastomosis 
or in the ileal pouch.5
Fibrosis is the result of complex interactions among 
inflammatory mediators including growth factors (ie, 
transforming growth factor β, insulin-like growth factor, 
platelet-derived growth factor, and basic fibroblast growth 
factor) and cytokines (ie, interleukin [IL]-13 and IL-17), 
which are all involved in driving changes in tissue architec-
ture and function. This can ultimately impact the structure 
and function of the small intestine and colon and can result 
in clinical symptoms.7
In the last two decades, the medical therapy for CD 
has improved remarkably, and the introduction of biolog-
ics has dramatically changed the therapeutic approach 
in both adults and children. However, CD strictures 
generally show a poor response to medical therapies, 
and surgical bowel resection or surgical strictureplasty 
are often required.8,9 Over the last three decades, the role 
of endoscopic balloon dilation in this clinical setting has 
increased vastly. Nowadays, it represents a valid comple-
mentary option.4
Epidemiology
At the time of diagnosis, intestinal strictures may occur in 
about 5%–10% of patients with CD.6,7 Up to one-third of the 
patients will develop intestinal strictures within 10 years of 
disease activity (mainly at the terminal ileum, ileocolonic, 
and colonic level).8,9
Though inflammatory strictures have the option of other 
medical treatments, 60%–70% of these patients will nev-
ertheless require surgery at follow-up.10 Moreover, a high 
rate of post-surgical relapses is observed: 40% at 4 years 
after bowel resection, and 50% at 10 –15 years after ileoce-
cal resection. Strictureplasty has also been associated with 
a risk of stricture relapse in 34% of the cases at 7.5 years. 
This implies that up to one-third of CD patients will undergo 
more than one surgery in their life course.11 Patients with 
early onset of disease have an increased risk of surgical 
relapse and a need of repeated resections, which may result 
in a short bowel syndrome.6
Factors that affect stricture formation can be broadly 
 categorized into clinical presentation parameters, serologic 
markers, and genetic susceptibility.4 Parameters that have been 
proved to correlate with stricturing CD behavior and worse 
disease outcome include smoking, lower educational level, and 
younger age at diagnosis.12 As outlined by the data from the 
TREAT™ registry (the Crohn’s therapy, resource, evaluation, 
and assessment tool), other factors that are associated with 
stricture formation include CD severity at the time of disease 
onset, CD duration, ileal disease, and use of corticosteroids.11
The role of serologic markers in predicting disease course 
in IBD is currently not completely defined, though generally 
perinuclear anti-neutrophil cytoplasmic antibody (pANCA) 
positivity is thought to correlate with a more benign, “UC-
like” clinical presentation, while ASCA antibody (anti-
Saccharomyces cerevisiae antibody), OmpC (Escherichia 
coli outer membrane porin C), Pseudomonas fluorescens-
associated sequence I2 (bacterial sequence I2) and Cbir1 
(flagellin) correlate with more complicated CD.13
Nucleotide-binding oligomerization domain 2(NOD2)/
caspase recruitment domain-containing 15 (CARD15) 
remains the most established genetic predictor of complicated 
CD, though it is not currently able to predict which patients 
should be targeted for more aggressive early intervention.14 
The three major polymorphisms reported with CD are 
Arg702Trp (SNP8), Gly908Arg (SNP12), and Leu1007insC 
(SNP13), and they have been associated with ileal disease, 
stenosis, and need for surgery.4,14 Apart from NOD2, other 
genetic markers for CD confirmed in multiple populations 
include ATG16L1 (autophagy-related 16-like1 gene) and 
IL-23R (IL-23 receptor gene).4
Diagnostic techniques: the role  
of radiologists and endoscopists
Symptomatic CD patients often undergo diagnostic imaging 
studies for assessment of disease activity or complications 
including bowel strictures and obstructions.15 It is vital to 
differentiate between inflammatory versus fibrous-predom-
inant strictures, as the optimal therapy will consequently 
differ.16
intestinal ultrasound
Intestinal ultrasound (US) represents a useful option to 
evaluate aspects including wall thickness, transmural com-
plications, color Doppler grade, quantitative analysis of 
the contrast enhancement, and the presence and severity of 
strictures. Ripollés et al investigated the accuracy of several 
US parameters for evaluation of mural inflammation in CD, 
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referring to the related histopathology findings.16 They report 
a good correlation between the sonographic and pathology 
scores, for both inflammatory and fibrostenosing strictures. 
According to this study, US can be a useful tool for distin-
guishing inflammatory from fibrostenotic lesions in CD.16
Magnetic resonance enterography  
and computed tomography
Computed tomography (CT) and magnetic resonance 
enterography (MRE) are now widely used in patients with 
CD, both for diagnosis and monitoring.17 These techniques 
have almost completely replaced traditional barium small 
bowel follow-through studies.7 MRE provides information 
regarding disease activity, chronicity, and stricture forma-
tion without using ionizing radiation.15 A retrospective 
study by Ha et al (Table 1) showed that MRE provides an 
effective alternative to CT for evaluating and directing care 
in CD patients, particularly those presenting with obstruc-
tive symptoms.15 Positive findings of CD including active 
inflammation, stricturing, and penetrating disease were more 
frequent in patients with obstructive symptoms, in respect to 
other indications (P=0.001).15
Other supporting data are provided in a retrospective 
study by Patel et al (Table 1), who sought to assess the use of 
MRE for management of IBD in a single medical center.17 The 
authors validated the potential of enterography in revealing 
active disease and its complications, which are not evident 
on endoscopy (including strictures, perianal fistulas, and 
abscesses). They concluded that MRE should be considered 
in the initial diagnosis, assessment of disease activity, and 
monitoring of therapy in patients with IBD.17
Small bowel endoscopy
The role of small bowel endoscopy (SBE) for diagnosis and 
assessment in pediatric patients with suspected or established 
CD was investigated in a prospective cohort study conducted 
by Di Nardo et al.18 On the basis of the success rate and of the 
absence of complications, the authors concluded that SBE 
is a useful and safe endoscopic procedure for evaluating the 
small bowel in pediatric patients with CD. In fact, not only 
does it have the potential to provide a definite diagnosis of 
CD when this is uncertain, but it is also an effective option 
in the management of small-bowel strictures, thus allowing 
clinicians to avoid surgery.18
Table 1 Diagnostic techniques for stenosing Crohn’s disease. Synopsis of main papers cited in this review
Authors Study type Number of patients Main findings Conclusions
Ha et al15 Retrospective 
cohort study
119 Crohn’s disease  
pts; 133 MRe scans
Positive findings of Crohn’s disease (eg, active 
inflammation, stricturing, and penetrating disease);  
more frequent in pts with obstructive symptoms  
(87.5%) vs other indications (58.1%) (P=0.001) 
in the subgroup of pts with obstructive symptoms,  
MRE findings assisted in directing a change of clinical  
management toward escalation of medical therapy in  
55% and surgery in 32.5% pts, respectively 
Review of surgical resection specimens confirmed MRE  
findings of disease activity and fibrosis in 92% of cases
MRe provides an effective 
alternative to CT for evaluating 
and directing care in Crohn’s 
disease pts, particularly those 
presenting with obstructive 
symptoms
Ripollés et al16 Prospective 
cohort study
25 Crohn’s disease pts Good correlation between the US and pathology  
scores, for both inflammatory and fibrostenosing  
strictures 
Significantly negative association between the color  
Doppler grade and the pathologic fibrostenotic score
US and CeUS: useful tools for 
distinguishing inflammatory 
from fibrostenotic lesions in 
Crohn’s disease US yields 
useful information for the 
management of Crohn’s disease
Patel et al17 Retrospective 
cohort review
270 iBD pts; 
258 Crohn’s disease  
pts; 311 enterography 
studies (291 MRE and  
20 CT enterographies)
Active SB disease noted in 73/311 (23.5%) of studies 
Complications (eg, strictures, perianal fistulas,  
abscesses, and SB fistulas) noted in 108/311 (34.7%)  
of studies 
Endoscopic and enterography defined active disease  
had an agreement of κ=0.36 in the ileum (n=179) 
142/311 (45.7%) enterographies were associated with  
recommended medication changes within 90 days 
Surgery or eBD of stricture recommended following  
41/311 (13.2%) enterographies
enterography reveals active 
disease and complications not 
evident on endoscopy 
enterography should be 
considered in the initial 
diagnosis, assessment of disease 
activity, and monitoring of 
therapy in pts with iBD
Abbreviations: CT, computed tomography; eBD, endoscopic balloon dilatation; MRe, magnetic resonance enterography; pts, patients; SB, small bowel; vs, versus; US, 
ultrasound; IBD, inflammatory bowel disease; CEUS, contrast-enhanced ultrasound.
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Medical availabilities: the role 
of gastroenterologists and 
pediatricians
While potent anti-inflammatory medications have reduced 
the symptoms of CD, more than 60% of patients eventually 
require surgery due to the development of fibrosis.19 Even 
after the introduction of biologics, the population-based rate 
of surgery for CD has not decreased. This might be due to 
late initiation of these therapies, after the fibrosis cascade 
is unstoppable. To date, no specific intestinal antifibrotic 
therapy exists.7 Despite the lack of data in literature, azathio-
prine has been shown to reverse the inflammatory changes 
at the anastomotic site and to maintain remission in patients 
with CD.20
The role of biological therapy in case of CD strictures 
remains controversial.21–24 Because of reports of complete 
obstruction after treatment with infliximab in patients with or 
without initial stricture, its use was contraindicated in stenotic 
forms of CD by some authors.21–24 Theoretically, the rapid 
tissue healing induced by infliximab administration may 
result in marked architectural changes in the intestinal wall, 
which can lead to wall stricturing.25 However, strictures do not 
occur without inflammation, and chronic inflammation per 
se may lead to strictures. In fact, a long-term inflammatory 
process sustained by increased cytokine production results in 
an excess of fibrotic response. On the other hand, substantial 
thickening of the mesenchymal layers is observed during 
mucosal repair. According to the latest evidence, the control 
of chronic inflammation to prevent fibrosis and stenosis 
seems more important than the risk of fibrosis induced by 
treatment, thus justifying infliximab infusions.23,24,26
Govani et al reviewed the evidence that suggests early 
aggressive therapy is beneficial, especially in patients diag-
nosed before the age of 40 years, and with ileal or perianal 
disease. Patients with symptomatic strictures may benefit 
from early surgery (before penetrating complications) fol-
lowed by initiation of biologics. With increased early use of 
biologics and better control of inflammation, a global reduc-
tion in intestinal fibrosis and related complications arising 
from CD should be expected.19
The role of surgeons
CD is usually managed medically, without surgery, while 
surgery is mostly indicated for complications that do not 
respond to other medical management. Within 13 years of 
the disease onset, an estimated 74% of cases require surgery. 
Also, in the subsequent 10-year follow-up period, the rate of 
relapse is about 30%–50%.27 Chronic fibrosis and scarring 
that do not respond to conservative management necessitate 
surgery, and 25% of patients with CD undergo surgery for 
intestinal obstruction.27 CD patients with ileocolonic disease 
do worse with medical therapy (P=0.026) and may require 
surgery sooner than patients with ileal disease (P=0.023).28 
A removal/resection is required in case a longer segment of 
intestine is involved or when multiple strictures that preclude 
a simple strictureplasty are present.27 As an alternative to 
intestinal resection, fibrotic strictures can be treated with 
strictureplasty.29 Although the latter has the advantage of 
preserving bowel length, it is still associated with a significant 
operative recurrence rate of 34% during a median follow-up 
period of 7.5 years.10
There are 15 distinct strictureplasty methods described, 
though the two most commonly employed for CD are the 
Heineke–Mikulicz and the Finney methods. In particular, 
jejuno–ileal disease offers the widest choice for types of 
strictureplasty, and generally a Heineke–Mikulicz procedure 
is used for a shorter disease extent (,5–10 cm), whereas the 
Finney or Jaboulay procedures are used for longer segment 
strictures. Modified procedures include Judd, Moskel, Walske, 
 Neumayer, and isoperistaltic strictureplasties.30,31  According to 
a 2007 meta-analysis that analyzed 1,112 patients with a total 
of 3,259 strictureplasties, this approach has a complication 
rate of 4% (including leak, fistula, and abscess) and a recur-
rence rate of 28% by 5 years (Table 2).32
A colectomy can be required when significant or large 
segments of the colon are involved. An anastomosis between 
the ileum and the rectum can be performed when the rec-
tum is free of disease.27 A segmental colectomy represents 
a possible option when a short segment is involved, and 
the patient has not presented with a significant number of 
complications or recurrences.33 A proctocolectomy is needed 
when the rectum is involved, and an ileostomy is usually 
performed in conjunction.27 Ileo-anal pouch anastomosis is 
a surgical procedure done between the ileum and anus after 
proctocolectomy. This procedure is usually not an option for 
CD, as the terminal ileum, which is used to form the pouch, 
is likely to relapse.27
The surgical management of CD has advanced consider-
ably over the past two decades. Surgeons are more specialized, 
and minimally invasive techniques have been introduced from 
which young patients with CD benefit in particular. Moreover, 
thanks to improved indications to surgery, such options still 
represent, at present, a valuable alternative to long-term medi-
cal treatments in selected patients. A number of studies have 
compared short-term outcomes associated with laparoscopic 
and with open approaches for ileocolic resections in patients 
Journal of Multidisciplinary Healthcare 2015:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
171
Management of strictures in patients with Crohn’s disease
with non-penetrating primary CD, though only two of these 
studies are randomized controlled trials (RCT).19,20 These 
findings clearly favored the laparoscopic approach over its 
open counterpart in terms of postoperative morbidity and 
length of hospital stay, despite the higher costs for the longer 
operative time. No increase in morbidity or mortality rates 
was observed.34,35
Although surgical treatment is effective for CD stric-
tures, there is invariably a high risk of recurrence of CD. 
Medications used in the treatment of CD, such as immuno-
suppressants, render the patients more prone to complications 
and post-surgical procedures.27 Symptomatic recurrence is 
usually seen in approximately 30% of patients at 3 years, with 
considerably increasing incidence in 10 years. In 20 years, 
surgery for recurrence is estimated at 70%. Anastomosis 
sites are the most common locations of recurrence. In the 
immediate postoperative period, thickening of the loops 
may be reactive. Obstruction of the bowel due to disease 
recurrence or the presence of extensive adhesions requires 
surgical correction.27 Repeated surgery can result in com-
plications related to short bowel syndrome, requirement for 
total parenteral nutrition, and related complications. Younger 
patients tend to run an aggressive course with a shorter dura-
tion to reoperation.2
The role of operative endoscopy
The advent of endoscopy in the management of complicated 
CD strictures has changed the approach to the management 
of anastomotic and small bowel strictures in these patients. 
Balloon enteroscopy now allows the assessment of areas 
not deemed possible in the past for dilations.36 Endoscopic 
balloon dilation (EBD) is a minimally invasive technique 
that can reduce or delay the need for surgery in patients with 
CD-related strictures.6,37
There have been several studies aimed at reporting the 
clinical efficacy, technical feasibility and short and long term 
results of EBD.6,36,37 Almost all studies have used resolution 
of symptoms and/or surgery-free period as outcomes. Most 
studies included had less than 60 patients.36,37
According to current knowledge, EBD in CD strictures 
appears to be a safe technique (technical success rate of 
70%–95%, defined as achieving an endoscopically passable 
residual stricture) with a low complication rate (0%–10%). 
Usually, more than one dilatation session is required for every 
stricture. Complications such as hemorrhages are rare, while 
perforations are reported mostly in studies in which 25 mm 
balloons are used. Up to 47% of CD patients show a long-term 
global benefit, ie, a surgery-free period at 3-year follow-up.38,39 
Moreover, with the new generation of double or single endo-
scopic balloon enteroscopy, this procedure can be performed 
at almost any level of the gastrointestinal tract, which allows 
for conserving the bowel length.37,40 The only factor that was 
proved to significantly affect dilatation efficacy and surgery-
free follow-up was the stricture length. In contrast, naïve vs 
post-surgical, steroid injection, and active vs inactive CD were 
all deemed to be non-significant.36
Up to now, EBD has been shown to be equally effective 
in adult and pediatric CD patients. The endoscopic manage-
ment of CD strictures is of particular importance in children, 
considering the long life expectancy of these patients together 
with the major consequences of developing a short bowel 
syndrome, if repeated surgical resections are performed. 
Moreover, many clinical concerns are related to malnutrition 
and subsequent failure to thrive in children with obstructive 
condition or post-large bowel resections.6,41 EBD could also 
be taken into consideration as an adjunct to surgery, given 
that it has been shown to add at least 50% efficacy to the 
initial surgery by prolonging the surgery-free period.36
It is difficult, at present, to define the relapse risk after 
EBD, as the published studies are based on very different 
follow-up periods. According to a prospective long-term 
study by Stienecker et al, stricture relapses were observed 
in 46% of patients after a mean of 32 months. Endoscopic 
re-dilatation was successful in 64% of the patients with 
relapsing strictures, and the long-term success rate was 80%. 
On the basis of these long-term results, the authors concluded 
that EBD, repeated if necessary, is comparable to surgical 
treatment, whereas the relapse rate after a single balloon 
dilatation is probably higher than after surgical intervention 
(Table 2).37
De Angelis et al evaluated short- and long-term efficacy 
of EBD in a cohort of consecutive patients with symptom-
atic CD-related strictures (Table 2).6 Both naïve and post-
operative strictures of any length or diameter, with or without 
associated fistula, were included. During the follow-up time, 
the technical success of EBD was 100%, there were no 
procedure-related complications, and surgery was avoided 
in 92.6% of the patients. Two patients, both presenting with 
ileocecal strictures associated with fistula, failed to respond 
to treatment and underwent surgical stricture resection. No 
difference was observed between the EBD success rate for 
naïve and postoperative CD related strictures (P.0.05). The 
authors of that study concluded that EBD appears to be a 
safe and effective procedure in the therapeutic management 
of CD-related strictures of any origin and dimension in order 
to prevent surgery.6
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Management of strictures in patients with Crohn’s disease
A study performed by Chen and Shen showed that the 
efficacy and safety of EBD in the treatment of strictures is 
comparable for CD and non-CD related strictures (Table 3).42 
Three larger studies have recently been performed to assess 
the efficacy of EBD for Crohn’s strictures.4,38,43,44 All the 
studies used a Boston Scientific through the scope balloon, 
12–25 mm in diameter, and conscious sedation. Mueller 
et al (Table 3) investigated 55 patients, mostly with de novo 
strictures (69%) and reported an initial success rate of 95%.43 
Moreover, 76% of patients never required repeat treatment 
during the follow-up period. They also reported a statistically 
significant correlation between the need for surgery and 
stricture length (P=0.006), with average stricture requiring 
surgery being 7.5 cm vs 2.5 cm for the strictures amenable 
to endoscopic therapy. One patient was perforated.43
Scimeca et al (Table 3) followed 37 CD patients pro-
spectively (39 strictures, 72 dilations) at a single centre. The 
strictures were mostly post-surgical (97%), with 77% being at 
ileocolonic anastomosis sites. The success rate post-first dila-
tion was 51%, and the overall success rate (after subsequent 
dilations) was 89%. No complications were reported.38 The 
Gustavsson et al retrospective study (Table 3) included a total 
of 178 patients, most of whom had either ileal or ileocolonic 
disease, and approximately 40% had stricturing disease at 
presentation (anastomotic or de novo). At 5 years, 52% of 
patients had at most one additional dilation, and 36% had a 
surgical resection.44
Recently, a combined medical and endoscopic therapy 
has been shown to be effective in the treatment of CD-related 
strictures. EBD should therefore be considered, together 
with the medical therapy, as an option to bridge the patient 
to surgery in better performance conditions (eg, nutrition, 
inflammatory status), shifting from emergency to elective 
surgery.6 In cases of multiple strictures, based on their clinical 
experience, Stienecker et al suggested that only one stricture 
should be dilated in each session. Strictures of more than 
5 cm in length should instead be treated surgically. Fistulas 
originating from the stricture were considered contraindica-
tions for EBD (Table 3).37
The use of intralesional injection  
of medications in stricturing CD
Given the high rate of stricture recurrence after dilatation, 
intralesional injection of medications has also been stud-
ied.45–47 Nowadays, it is still unknown whether additional 
medical treatment can influence the recurrence rate.36 
Raedler et al treated 30 patients after successful dilatation 
of ileocecal strictures with azathioprine and budenoside or 
with placebo. After both 6 and 12 months, the patients in 
the placebo group presented with a statistically significant 
greater number of symptoms due to strictures, and needed 
surgical interventions more frequently.46 A pediatric study of 
29 patients also reported a significant trend in patients, who 
did not receive intralesional steroids, toward re-dilatation 
and surgery.47
However, another study that investigated single treatment 
of intrastricture triamcinolone injection did not prove any 
reduction in the time to re-dilatation after EBD of CD ileoco-
lonic anastomotic strictures (Table 3).45 Moreover, Thienpont 
et al observed no significant effect of active disease at the 
time of dilation or systemic medical therapy afterwards, on 
re-dilation or surgery (Table 3).48 The effect of intralesional 
injection of infliximab has been studied in a small number 
of patients and consensus is lacking. Thus, there is no clear 
evidence at this time to support the role of intralesional injec-
tion of medications following dilation.
The use of extractible metallic  
stents in stricturing CD
The use of extractible metallic stents has also been consid-
ered as a possible alternative to EBD, in order to lower the 
number of recurrences. Levine et al (Table 3) undertook a 
retrospective review of all patients undergoing endoluminal 
stenting for CD strictures.49 Five patients underwent this 
procedure with a 100% rate of technical and an 80% rate of 
clinical success. There was one complication involving re-
obstruction, which required surgical intervention; there were 
no mortalities. The authors concluded that stenting of CD 
strictures is a safe and effective alternative to surgery, which 
can provide lasting benefit in selected patients.49
A prospective pilot study conducted by Attar et al 
(Table 3) aimed at investigating the feasibility and clinical 
effectiveness of the use of extractible stents in the treatment of 
CD intestinal strictures.50 Eleven patients were prospectively 
included and were treated with transitory stent placement, 
which was technically successful in ten patients. Obstruc-
tive symptoms were relieved in six out of ten patients. Two 
patients needed surgery related to the procedure, and six 
downstream migrations were observed.50 The authors con-
cluded that although stenting appears an effective technique 
in treating symptomatic CD intestinal strictures, the proce-
dure is associated with a prohibitively high rate of spontane-
ous migrations and complications.50 Other recent studies that 
have used self-expanding metallic and biodegradable stents, 
and report a high incidence of migration.2,49,50 Nevertheless, 
clinical success has ranged from 45%–80%. The majority 
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of stents in these studies were placed in postsurgical stric-
tures.2 Overall, metal stents have been reported as an effec-
tive alternative to surgery for the palliation of patients with 
colorectal neoplastic obstruction.2 However, at present, the 
role of endoluminal stenting in benign obstruction, especially 
for CD, is still controversial, with limited data and widely 
disparate outcomes.49,50
Practical guidelines for the  
management of strictures in CD
The European Panel on the Appropriateness of CD Therapy 
(EPACT II)51 have developed appropriateness criteria for the 
management of CD strictures. Moreover, a flow chart on this 
topic is also outlined in a recent review by Rieder et al.7 In 
summary, when clinical symptoms of intestinal obstruction 
appear in patients with CD, a radiologic assessment of bowel 
obstruction and an evaluation for active intestinal inflamma-
tion are prompted. When intestinal strictures are documented, 
anti-inflammatory treatments are recommended if signs of 
active disease are present; if this is not the case, a fibrotic 
stricture should be presumed, and its location, number, angu-
lation, and diameter of the narrowed tract (. or ,4 cm) need 
to be assessed. Once the diagnostic assessment is completed, 
options including surgical resection, strictureplasty, or endo-
scopic dilatation have to be evaluated.7,51
Indications for strictureplasty include: presence of 
multiple strictures over extensive length of bowel, previous 
significant small bowel resection (.100 cm), short bowel 
syndrome, strictures without phlegmon or septic fistula, duo-
denal strictures, and anastomotic strictures. Contraindications 
include: associated abscess or phlegmon, perforation with 
diffuse peritonitis, suspicion of carcinoma in the stricture, 
or poor nutritional status.  Strictureplasty can be performed 
safely in active disease.7,51
Oncological strictures
Patients with IBD and dysplasia have pathologic characteris-
tics and risks that differ from those of patients with sporadic 
carcinomas. Therefore, surgical interventions need to be more 
aggressive in this group of patients than in sporadic cases.52 
Only 1%–2% of all general colorectal cancer (CRC) cases 
per year are diagnosed as CRC arising in IBD. However, 
as 15% of all IBD deaths are associated with CRC, cancer 
screening is particularly required in this group. It has to be 
considered that cancers in patients with UC and CD often 
present not as mass lesions, but as dysplasia, strictures, or 
diffuse dysplasia. The risk for CRC development is lower 
before 8–10 years after symptom onset (3%). The rates of 
CRC in CD (associated with a 5- to 20-fold increase in risk, 
in comparison with the general population) seem to mirror 
those of UC.53,54
Cancer in CD is more likely to be right-sided and 
associated with ileal and right-sided colonic location.52,54 
Colonic strictures are more common in CD (5%–17% 
of patients) than in UC (5% of patients). Thanks to the 
medical treatments currently available, which allow 
more patients to achieve remission, the rate of stricture 
occurrence seems to be improving nowadays.52,54 Colonic 
strictures should be considered malignant until proven 
otherwise.52 A study by Gumaste et al found that 29% of 
strictures in UC patients were malignant, whereas this 
malignancy rate was encountered in only 6.8% of CD 
colorectal strictures.55
Strictureplasty is not indicated as primary management 
of colonic strictures in IBD. Strictures found at prior anas-
tomotic sites in CD may be carefully dilated to allow endo-
scopic evaluation of recurrence or surgical complications 
from the original resection.52,56 Dysplasia and carcinoma at 
colonic strictures cannot always be detected preoperatively. 
Ideally, a stricture should be traversed, adequately examined, 
and biopsied. Nevertheless, a risk of sampling error can still 
occur.52,56 Oncology resection is indicated any time malig-
nancy cannot be excluded.52,56
While in UC proctocolectomy represents the only option 
to get to a definitive diagnosis or to rule out a carcinoma and 
to treat possible multifocal malignancy, in CD colorectal 
stricture, a segmental oncologic resection may be appropriate 
in a patient with limited segmental disease.52
In summary, identification and treatment of dysplasia 
and CRC in IBD is a challenging task for clinicians.52 As 
sporadic adenomas and inflammatory-related dysplasia in 
patients with IBD are associated with a different type of 
risk for the patient, the treatment strategy should therefore 
be modulated accordingly. Surgical interventions should be 
based on disease location, finding of dysplasia, and patient 
morbidities. Although the gold standard for oncologic resec-
tion remains total proctocolectomy, many appropriate options 
exist that are aimed at intestinal continuity.52
Perianal strictures
Perianal CD (PCD) comprises fistulizing lesions (fistulas 
and abscesses) and non-fistulizing lesions (fissures, ulcers, 
and strictures). While fistulizing PCD has been thoroughly 
described and analyzed by guidelines and literature, respec-
tively, data on non-fistulizing PCD remain scarce.  Anorectal 
strictures in CD are either associated with fistulizing 
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PCD or are a long-term consequence of the inflammatory 
process.57
According to the Cardiff-Hughes classification, strictures 
are graded on a scale ranging from 0–2 (0= not present, 
1= reversible stricture, and 2= irreversible stricture), and 
location-wise, they are distinguished as anal or lower rectum 
strictures. Although strictures S1 are mainly inflammatory, 
and strictures S2 tend to be fibrotic, in most cases both inflam-
matory and fibrotic compounds occur in association.58
In order to assess the natural history and long-term out-
comes of anorectal strictures, Brochard et al57 reviewed all 
outcomes of patients with non-fistulizing PCD followed in a 
single unit, as well as subsequent therapeutic management. 
Out of a total of 102 CD patients, 59% achieved anorectal 
stricture healing after a median follow-up period of 2.8 years. 
An unfavorable course (defined as persistent stricture S2, 
or persistent stoma, or proctectomy at the end of follow-up) 
was seen in 32% of patients at the end of follow-up, and two 
patients developed anal adenocarcinoma. A multiple regres-
sion analysis showed that female gender, disease duration of 
CD of less than 10 years, and anal fistula at stricture diagnosis 
were significantly associated with anorectal stricture healing. 
Moreover, gender and introduction or optimization of tumor 
necrosis factor alpha (TNFα) antagonist treatment were associ-
ated with a decreased risk of unfavorable course. Conversely, 
the luminal B2 phenotype at CD diagnosis was the only factor 
associated with unfavorable course. The authors concluded that 
anorectal strictures related to severe perianal CD should not 
be considered as a non-reversible and complicated condition. 
In fact, in the era of biologics, this study shows a healing rate 
of anorectal stricture for more than 50% of patients after a 
3-year follow-up period. Nevertheless, the need for stoma or 
proctectomy was required in approximately 25% of patients, 
which suggests that the presence of anorectal stricture still 
remains a marker of disease severity.57
Dietary management:  
the role of dieticians
Given that CD is a debilitating chronic inflammatory condi-
tion of the bowel, it is of fundamental importance to promote 
an appropriate use of diet and nutritional therapy as part of 
the disease management. The British Dietetic Association 
has developed evidence-based guidelines on the dietary 
management of CD in adults, aimed at reducing variation in 
clinical practice. These guidelines include dietary manage-
ment of stricturing disease.59 The guidelines state that after 
a course of enteral nutrition for induction of remission, food 
re-introduction diets may be useful to help maintain disease 
remission. Dietary fiber is contraindicated in the presence of 
strictures because of the risk of mechanical obstruction.59
Conclusion
Stricture formation is a common complication of CD, 
occurring in approximately one-third of all patients with 
this condition. CD fibrotic strictures generally show poor 
response to medical therapies, and surgical bowel resection 
or surgical strictureplasty are often required.
Endoscopic dilatation represents a valuable treatment 
of small and large bowel strictures, with an acceptable rate 
of complications. EBD and surgery should not be seen as 
mutually exclusive alternatives for treating CD strictures; 
rather, EBD may be a complementary low-risk procedure 
that should be considered in both adult and pediatric patients 
in order to reach a symptom-free condition.
At present, given the complexity in reaching such a 
condition, the management of patients with stricturing CD 
requires a multidisciplinary approach. Gastroenterologists, 
pediatricians, radiologists, surgeons, specialist nurses, and 
dieticians are among the health care providers involved in 
supporting these patients throughout diagnosis, prevention 
of complications, and treatment.
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